Status:

TERMINATED

Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor

Lead Sponsor:

University of Medicine and Dentistry of New Jersey

Collaborating Sponsors:

National Institutes of Health (NIH)

Conditions:

Esophageal Metaplasia

Eligibility:

All Genders

18-80 years

Phase:

PHASE3

Brief Summary

In this project, we are trying to identify patients with the earliest signs of abnormality in the lining of the lower part of the food pipe (or esophagus) known as intestinal metaplasia (IM); also com...

Detailed Description

We propose to study prospectively 68 patients who have been identified as positive with mAb DAS-1 immunostaining without histological evidence of specialized columnar epithelium ("True Barrett's" epit...

Eligibility Criteria

Inclusion

  • Dyspeptic symptoms, upper abdominal pain, heartburn, regurgitation;
  • Endoscopically - normal appearing GE junction, irregular z-line, or erosive esophagitis up to Grade 2.

Exclusion

  • Barrett's esophagus (Endoscopically greater than 2 cm of columnar epithelium on endoscopy and the presence of specialized columnar epithelium on histology);
  • Patients who have been taking a PPI longer than the 3 months proceeding study entry. Patients currently taking a PPI but for less than 3 months who are not willing to discontinue PPI treatment for 4 weeks prior to enrollment into this study.
  • Severe esophagitis Grade 3 or 4
  • Documented active duodenal or gastric ulcer (at least 0.5cm diameter). Patients with erosions can be included.
  • Presence of esophageal varices
  • History of gastric surgery altering normal anatomy (eg, Billroth procedure, gastric bypass)
  • Pregnant or nursing patients

Key Trial Info

Start Date :

December 1 2002

Trial Type :

INTERVENTIONAL

End Date :

October 1 2006

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00161200

Start Date

December 1 2002

End Date

October 1 2006

Last Update

December 11 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cancer Institute of New Jersey

New Brunswick, New Jersey, United States, 08901